Maryland Governor Announces Partnership With CareFirst For 'Doughnut Hole' Subsidy
Main Category: Medicare / Medicaid / SCHIPArticle Date: 20 Feb 2008 - 9:00 PDT
Maryland Gov. Martin O'Malley (D) on Friday announced a partnership with CareFirst BlueCross BlueShield to subsidize prescription drug costs for lower-income beneficiaries who fall into the so-called "doughnut hole" coverage gap of the Medicare drug benefit, the Baltimore Sun reports. The gap begins when drug costs for an individual reach $2,510 and ends when spending reaches $5,725.
Under the partnership, residents with annual incomes up to 300% of the federal poverty level would receive a subsidy during the coverage gap. The amount of the subsidy would vary based on how far seniors fall into the gap. The subsidy, which is expected to cost $7 million annually, would be paid for by CareFirst and would not require state funds. Chester Burrell, CEO of CareFirst, said that the subsidy will help the insurer fulfill its public service mission, as well as lower hospital costs that are a result of Medicare beneficiaries not taking their medications. The partnership needs approval from the General Assembly (Smitherman, Baltimore Sun, 2/15).
Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation© 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.
|
Please rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add to:
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
| Back to top | Back to front page | List of All Medical Articles |
| Privacy Policy | Terms and Conditions | © 2008 MediLexicon International Ltd |





